Market Tracker

07/23 12:01pm ET

Nektar Therapeutics (NASDAQ:NKTR)

11.00
Real-Time Quote
 -0.02 / -0.18%
Today’s Change
8.87
Today|||52-Week Range
15.34
-3.08%
Year-to-Date

Today’s Trading

Previous close11.02
Today’s open11.13
Day’s range10.95 - 11.22
Volume444,626
Average volume (3 months)1,127,015
Market cap$1.4B
Dividend yield--
Data as of 11:46am ET, 07/23/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+55.10%
Earnings growth (next 5 years)+33.06%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...+0.07+0.49%
DYAXDyax Corp+0.41+4.66%
ABCOAdvisory Board Co+0.50+1.00%
ARIAARIAD Pharmaceutical...+0.18+3.53%
Data as of 12:01pm ET, 07/23/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts